FentaNYL Citrate Injectable Solution recalled over manufacturing violations
- Recall date
- April 1, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houst…
- Recall number
- D-0503-2026
- FDA classification
- Class II
- Brand / firm
- Wells Pharma of Houston LLC
- Sold / distributed
- U.S. Nationwide.
Why it was recalled
cGMP deviations.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02.
Get recall alerts
Free email alert whenever Wells Pharma of Houston LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Wells Pharma of Houston LLC